These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28185649)

  • 21. Orbital decompression in Graves' orbitopathy: efficacy and safety.
    Goh MS; McNab AA
    Intern Med J; 2005 Oct; 35(10):586-91. PubMed ID: 16207257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of combined orbital radiation and systemic steroids in the management of Graves' orbitopathy.
    Kim JW; Han SH; Son BJ; Rim TH; Keum KC; Yoon JS
    Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):991-8. PubMed ID: 26876240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study.
    Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Rocchi R; Barbesino G; Mazzi B; Bartolomei MP; Lepri P; Cartei F; Nardi M; Pinchera A
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3562-7. PubMed ID: 11502779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Orbital scintigraphy with [111In-diethylenetriamine pentaacetic acid-D-phe1]-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy.
    Colao A; Lastoria S; Ferone D; Pivonello R; Macchia PE; Vassallo P; Bonavolonta G; Muto P; Lombardi G; Fenzi G
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3790-4. PubMed ID: 9814448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Graves' ophthalmopathy: the clinical and psychosocial outcomes of different medical interventions - a systematic review.
    Bello OM; Druce M; Ansari E
    BMJ Open Ophthalmol; 2024 Jun; 9(1):. PubMed ID: 38886120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trial.
    Wakelkamp IM; Baldeschi L; Saeed P; Mourits MP; Prummel MF; Wiersinga WM
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):323-8. PubMed ID: 16117821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endoscopic orbital decompression for optic neuropathy in thyroid ophthalmopathy.
    Tang IP; Prepageran N; Subrayan V; Tajunisah I
    Med J Malaysia; 2008 Oct; 63(4):337-8. PubMed ID: 19385499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three dimensional orbital magnetic resonance T2-mapping in the evaluation of patients with Graves' ophthalmopathy.
    Hou K; Ai T; Hu WK; Luo B; Wu YP; Liu R
    J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):938-942. PubMed ID: 29270757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical and surgical treatment of thyroid eye disease.
    Hall AJH; Topliss DJ
    Intern Med J; 2022 Jan; 52(1):14-20. PubMed ID: 32975863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rituximab treatment of patients with severe, corticosteroid-resistant thyroid-associated ophthalmopathy.
    Khanna D; Chong KK; Afifiyan NF; Hwang CJ; Lee DK; Garneau HC; Goldberg RA; Darwin CH; Smith TJ; Douglas RS
    Ophthalmology; 2010 Jan; 117(1):133-139.e2. PubMed ID: 19818507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Corticosteroids and radiotherapy in the treatment of Graves' ophthalmopathy].
    Nasr E; Khater S; Nehme-Nasr D; Azoury F; Jambart S
    J Med Liban; 2010; 58(2):86-90. PubMed ID: 20549894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endoscopic orbital decompression for Graves' ophthalmopathy.
    Levy J; Puterman M; Lifshitz T; Marcus M; Segal A; Monos T
    Isr Med Assoc J; 2004 Nov; 6(11):673-6. PubMed ID: 15562804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tocilizumab for the Management of Corticosteroid-Resistant Mild to Severe Graves' Ophthalmopathy, a Report of Three Cases.
    Maldiney T; Deschasse C; Bielefeld P
    Ocul Immunol Inflamm; 2020; 28(2):281-284. PubMed ID: 30457413
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy of rituximab treatment for thyroid-associated ophthalmopathy as a result of intraorbital B-cell depletion in one patient unresponsive to steroid immunosuppression.
    Salvi M; Vannucchi G; Campi I; Rossi S; Bonara P; Sbrozzi F; Guastella C; Avignone S; Pirola G; Ratiglia R; Beck-Peccoz P
    Eur J Endocrinol; 2006 Apr; 154(4):511-7. PubMed ID: 16556712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Author's response: medical or surgical decompression of optic neuropathy in Graves' ophthalmopathy: the choice remains unclear.
    Wakelkamp IM; Wiersinga WM
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):408. PubMed ID: 16918966
    [No Abstract]   [Full Text] [Related]  

  • 36. Follow-up of extended pterional orbital decompression in severe Graves' ophthalmopathy.
    Korinth MC; Ince A; Banghard W; Gilsbach JM
    Acta Neurochir (Wien); 2002 Feb; 144(2):113-20; discussion 120. PubMed ID: 11862510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Orbital radiation therapy for Graves' ophthalmopathy: measuring clinical efficacy and impact.
    Hahn E; Laperriere N; Millar BA; Oestreicher J; McGowan H; Krema H; Gill H; DeAngelis D; Hurwitz J; Tucker N; Simpson R; Chung C
    Pract Radiat Oncol; 2014; 4(4):233-9. PubMed ID: 25012831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnosis and treatment of dysthyroid orbitopathy: a multidisciplinary disease].
    Leray B; Imbert P; Thouvenin D; Boutault F; Caron P
    J Fr Ophtalmol; 2013 Dec; 36(10):874-85. PubMed ID: 24239215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of moderate to severe orbitopathy: Current modalities and perspectives.
    Bouzehouane N; Borson-Chazot F; Abeillon J; Caron P
    Ann Endocrinol (Paris); 2021 Apr; 82(2):92-98. PubMed ID: 33676921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endoscopic orbital decompression for Graves' ophthalmopathy.
    Kasperbauer JL; Hinkley L
    Am J Rhinol; 2005; 19(6):603-6. PubMed ID: 16402649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.